Campus Career 【 display / non-display 】
-
2016.08-2018.03Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Psychiatry and Behavioral Sciences, Visiting Lecturer
-
2017.05-2020.03Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Psychiatry and Behavioral Sciences, Visiting Lecturer
-
2018.05-2019.04Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Division of Cognitive and Behavioral Medicine, Department of Psychiatry and Behavioral Sciences, Visiting Lecturer
-
2019.05-2020.03Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Psychiatry and Behavioral Sciences, Visiting Lecturer
-
2020.05-2024.03Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Psychiatry and Behavioral Sciences, Visiting Lecturer
-
2024.07-2024.09Tokyo Medical and Dental University, Student Support and Health Administration Organization, Health Administration Center, Associate Professor
-
2024.10-NowInstitute of Science Tokyo, Institute-wide Support Centers, Health Administration Center, -, Associate Professor
Published Papers & Misc 【 display / non-display 】
-
Ando K,Nakazawa K, Matsunaga S,Okada T. Overview of forensic outpatients on the Medical Treatment and Supervision Act in Japan International Journal of Law and Psychiatry. 2025.03; 100 ( PubMed, DOI )
-
MATSUNAGA S, Ando K.. Suicidal Behavior among Forensic Psychiatric Patients in Japan: Risk Factors and Implications for Treatment Forensic Sci Med Pathol. 2024.09; ( PubMed, DOI )
-
Oguchi Y , Miyake N, Ando K. Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey Neuropsychopharmacol Rep. 2024.04; 44 (2): 417-423.
-
Oguchi Y, Miyake N, Ando K.. Long-acting injectable antipsychotics as maintenance therapy for schizophrenia during the COVID-19 pandemic Neuropsychopharmacol Rep. 2024.01; 44 (1): 34-41. ( PubMed, DOI )